Periodontal disease is an inflammatory condition characterized by an aberrant immune response against a dysbiotic dental biofilm, with oxidative stress performing an essential role in its pathogenesis. This paper presents a patent mining, performed in the Orbit Intelligence patent database, related to antioxidant phytochemicals in the technological developments that are working to prevent and treat periodontal disease. To access the documents, the descriptors “PERIODONTAL” and “ANTIOXIDANT” were typed in the title, abstract, and claim search fields. A total of 322 patents demonstrate the growing interest in researching natural antioxidants for scientific and technological purposes. The top ten countries regarding the number of family patents produced were the United States, the European Office, Japan, South Korea, China, India, Mexico, Denmark, Canada, and Great Britain. The most cited compounds were vitamin C, green tea, quercetin, melatonin, lycopene, resveratrol, and curcumin. These compounds have been used for the technological development of gels, membranes, dentifrices, chewing gum, orally disintegrating film, mouthwash, mouth spray, and mouth massage cream and exhibit the ability to neutralize free radicals and reduce oxidative stress, a critical factor in the development and progression of periodontal diseases. The patent documents have shown that using antioxidant compounds in conjunction with traditional periodontal treatments is a promising area of interest in periodontal therapy.

Periodontal disease has a multifactorial etiology. The immune response to bacterial infection leads to the activation of osteoclasts, resulting in the resorption of alveolar bone and, ultimately, tooth loss. Standard clinical treatments typically include scaling and root planing, which may or may not involve surgical procedures and are often supplemented with antibiotics and antiseptic chlorhexidine to control the growth of periodontal pathogens. However, research indicates that chlorhexidine can produce adverse effects, and many periodontal pathogens have developed antibiotic resistance. Given these challenges, bioactive compounds derived from medicinal plants, particularly coumarins, present promising alternative treatment options. This study seeks to explore the therapeutic potential of umbelliferone for the treatment of periodontitis using the Orbit patent database, employing the search syntax: ((umbelliferone)/TI/AB/CLMS/KEYW AND (A61Q-011/00)/IPC/CPC). Umbelliferone has shown potential in developing advanced therapeutic products for periodontal treatment and preventing periodontitis. Its remarkable biological properties, may significantly enhance clinical strategies for managing periodontitis.